State of Wisconsin Investment Board’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-33,503
Closed -$1.97M 2495
2023
Q4
$1.97M Sell
33,503
-1,601
-5% -$90K 0.01% 1238
2023
Q3
$1.53M Sell
35,104
-150
-0.4% -$5.36K ﹤0.01% 1310
2023
Q2
$1.27M Sell
35,254
-5,565
-14% -$229K ﹤0.01% 1400
2023
Q1
$1.52M Buy
40,819
+2,866
+8% +$129K ﹤0.01% 1369
2022
Q4
$1.72M Sell
37,953
-1,651
-4% -$107K 0.01% 1355
2022
Q3
$2.77M Sell
39,604
-2,300
-5% -$170K 0.01% 1229
2022
Q2
$2.81M Buy
41,904
+7,052
+20% +$448K 0.01% 1269
2022
Q1
$2.87M Buy
34,852
+16,141
+86% +$1.65M 0.01% 1383
2021
Q4
$2.75M Buy
18,711
+174
+0.9% +$27K 0.01% 1188
2021
Q3
$3.28M Buy
18,537
+232
+1% +$37.3K 0.01% 1166
2021
Q2
$2.96M Sell
18,305
-52,913
-74% -$8.5M 0.01% 1193
2021
Q1
$12.2M Sell
71,218
-19,905
-22% -$3.94M 0.03% 658
2020
Q4
$20M Buy
91,123
+12,517
+16% +$2.71M 0.05% 409
2020
Q3
$13.1M Hold
78,606
0.03% 531
2020
Q2
$8.97M Buy
78,606
+13,000
+20% +$1.26M 0.02% 646
2020
Q1
$5.04M Buy
65,606
+12,295
+23% +$1.1M 0.02% 780
2019
Q4
$6.87M Buy
53,311
+15,911
+43% +$1.53M 0.02% 830
2019
Q3
$2.91M Buy
37,400
+6,300
+20% +$591K 0.01% 945
2019
Q2
$3.2M Buy
31,100
+3,500
+13% +$272K 0.01% 935
2019
Q1
$2.02M Buy
27,600
+6,900
+33% +$469K 0.01% 1007
2018
Q4
$878K Buy
20,700
+2,300
+13% +$91.7K ﹤0.01% 1160
2018
Q3
$867K Hold
18,400
﹤0.01% 1253
2018
Q2
$907K Buy
+18,400
New +$695K ﹤0.01% 1201

Other funds holding MRTX

State of Wisconsin Investment Board's MRTX Position: Q1 2024 in Review

State of Wisconsin Investment Board sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 33,503 shares — an estimated $1.97M sold.

State of Wisconsin Investment Board first reported a position in MRTX in Q2 2018 and held it in 23 quarters. The position peaked at $20M in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • State of Wisconsin Investment Board reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 33,503 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.97M.
  • State of Wisconsin Investment Board first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and held it in 23 quarters.
  • State of Wisconsin Investment Board's Mirati Therapeutics, Inc. Common Stock position peaked at $20M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2024, filed 14 May 2024.